Blood test finds hidden pancreatic cancer after treatment

Дата публикации: 30-06-2026 14:00:01

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer missed by standard testing, potentially helping physicians identify patients whose disease is more likely to return even when scans appear reassuring. The sensitive blood test focuses on KRAS, a genetic mutation that drives more than 90% of pancreatic cancers. The findings come as a new revolutionary drug targeting KRAS is showing substantial survival benefits and nearing FDA review.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival	0	7.13	04-06-2026
2	Ultrasensitive blood test predicts head and neck cancer relapse months earlier	5	7	10-06-2026
3	Blood test distinguishes neuroendocrine subtype of advanced prostate cancer	0	8	10-01-2024
4	New AI Tool Boosts Pancreatic Cancer Detection	0	14.83	25-06-2026
5	FDA approves landmark pancreatic cancer drug that's shown to improve survival	0	7.9	26-08-2026
6	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
7	Phoenix doctor testing new pancreatic cancer drug shown to potentially double patient survival rates	0	5.82	29-04-2026
8	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
9	Novel biomarker research offers new hope in the fight against colorectal cancer	7	8	06-07-2026
10	Scientists find the genetic switch that makes pancreatic cancer resist chemotherapy	0	7.97	03-03-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 8. Источник: medicalxpress.com.